Bristol-Myers Squibb announces expiration of cash tender offer
Bristol-Myers Squibb announced the expiration on May 26, 2015 of its previously announced cash tender offer for up to $500 million aggregate principal amount of certain of its outstanding debt securities. $534.4 million in aggregate principal amount of the notes were validly tendered. May 27, 2015